Skip to main content
SpringerLink
Log in

Current strategies in the diagnosis and management of lower extremity peripheral vascular disease

  • Clinical Reviews
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Peripheral vascular disease: Report by NHLI Panel on Peripheral Vascular Disease, Feb. 28–29, 1972.

  2. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc. 1985;33:13–8.

    PubMed  CAS  Google Scholar 

  3. Kannel WB, Skinner JJ, Schwartz M, Shurtleff D. Intermittent claudication incidence in the Framingham study. Circulation. 1970;41:875–83.

    PubMed  CAS  Google Scholar 

  4. Widmer LK, Greensher A, Kannel WB. Occlusion of peripheral arteries. A study of 6400 working subjects. Circulation. 1964;30:836–84.

    PubMed  CAS  Google Scholar 

  5. Dormandy J, Mahir M, Ascady G. et al. Fate of the patient with chronic leg ischemia. J Cardiovasc Surg. 1989;30:50–7.

    CAS  Google Scholar 

  6. Radack K, Wyderski RJ. Conservative management of intermittent claudication. Ann Intern Med. 1990;113:135–46.

    PubMed  CAS  Google Scholar 

  7. Findgarde F, Jelnes R, Bjorkman H, et al. Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Circulation. 1989;80:1549–56.

    Google Scholar 

  8. Cooke JP, Dzau VJ. The time has come for vascular medicine. Ann Intern Med. 1990;112:138–9.

    PubMed  CAS  Google Scholar 

  9. Zarins CK. The vascular war of 1988. JAMA. 1989;261:416–7.

    Article  PubMed  CAS  Google Scholar 

  10. McDaniel MD, Cronenwett JL. Basic data related to the natural history of intermittent claudication. Ann Vasc Surg. 1989;273–7.

  11. Criqui MH, Browner D, Fronek A, et al. Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease: an analysis of risk factors. Am J Epidemiol. 1989;129:1110–9.

    PubMed  CAS  Google Scholar 

  12. Peabody CN, Kannel WB, McNamara PM. Intermittent claudication. Surgical significance. Arch Surg. 1974;109:693–7.

    PubMed  CAS  Google Scholar 

  13. Imparato AM, Kim GE, Davidson T, Crowley JG. Intermittent claudication: its natural course. Surgery. 1975;78:795–9.

    PubMed  CAS  Google Scholar 

  14. Fowkes FGR. The measurement of atherosclerotic peripheral arterial disease in epidemiologic surveys. Int J Epidemiol. 1988;17:248–54.

    Article  PubMed  CAS  Google Scholar 

  15. Hughson WG, Mann JI, Garrod A. Intermittent claudication: prevalence and risk factors. Br Med J. 1978;1:1379–81.

    Article  PubMed  CAS  Google Scholar 

  16. Juergens JL, Barker NW, Hines EA Jr. Arteriosclerosis obliterans: review of 520 cases with special reference to pathogenic and prognostic factors. Circulation. 1960;21:188–95.

    PubMed  CAS  Google Scholar 

  17. Jonason T, Bergstrom R. Cessation of smoking in patients with intermittent claudication. Acta Med Scand. 1987;221:253–60.

    Article  PubMed  CAS  Google Scholar 

  18. Myers KA, King RB, Scott DF, Johnson N, Morris PJ. The effect of smoking on the late patency of arterial reconstruction in the legs. Br J Surg. 1978;65:267–71.

    Article  PubMed  CAS  Google Scholar 

  19. Spittell JA. Diagnosis and management of occlusive peripheral arterial disease. Curr Probl Cardiol. Chicago: Year Book Medical Publishers, January 1990;1–33.

    Google Scholar 

  20. Criqui MH, Fronek A, Klauber MR, Barret-Connor E, Gabriel S. The sensitivity, specificity, and predictive value of traditional clinical evalution of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation. 1985;71:516–22.

    PubMed  CAS  Google Scholar 

  21. Lederle FA, Walker JM, Reinke DB. Selective screening for abdominal aortic aneurysms with physical examination and ultrasound. Arch Intern Med. 1988;148:1753–6.

    Article  PubMed  CAS  Google Scholar 

  22. Allardice JT, Allwright GJ, Wafula JMC, et al. High prevalence of abdominal aortic aneurysm in men with peripheral vascular disease: screening by ultrasonography. Br J Surg. 1988;75:240–2.

    Article  PubMed  CAS  Google Scholar 

  23. Imparato AM, Bracco A, Kim GE, et al. Comparisons of three technics for femoral — popliteal arterial reconstructions. Ann Surg. 1973;177:375–80.

    Article  PubMed  CAS  Google Scholar 

  24. Doubilet P, Abrams HL. The cost of underutilization. Percutaneous transluminal angioplasty for peripheral vascular disease. N Engl J Med. 1984;310:95–102.

    Article  PubMed  CAS  Google Scholar 

  25. Schroll M, Munck O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60 year old men and women. J Chron Dis. 1981;34:261–9.

    Article  PubMed  CAS  Google Scholar 

  26. Reunanen A, Takkunen H, Aromaa A. Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand. 1982;211:249–56.

    Article  PubMed  CAS  Google Scholar 

  27. Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation. 1990;82:1925–31.

    PubMed  CAS  Google Scholar 

  28. Criqui MH, Coughlin SS, Fronek A. Noninvasively diagnosed peripheral arterial disease as a predictor of mortality. Circulation. 1985;72:768–73.

    PubMed  CAS  Google Scholar 

  29. Rose G, McCartney P, Reid DD, et al. Self administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med. 1977;31:42–8.

    PubMed  CAS  Google Scholar 

  30. Wilt TJ, Mascioli SR, Worthy AJ, et al. Ankle — brachial blood pressure index in the Multicenter Isradipine/Diuretic Atherosclerosis Study. Clin Res. 1991;39:587A.

    Google Scholar 

  31. Prineas RJ, Harland WR, Janzon L, Kannel W. Recommendations for use of non-invasive methods to detect atherosclerotic peripheral arterial disease-In population studies. Circulation. 1982;65:1561A-6A.

    PubMed  CAS  Google Scholar 

  32. Raines JK, Darling RC, Buth J, Brewster DC, Austen WG. Vascular laboratory criteria for the management of peripheral vascular disease of the lower extremities. Surgery. 1976;79:21–9.

    PubMed  CAS  Google Scholar 

  33. Bernstein EF, Fronek A. Current status of noninvasive tests in the diagnosis of peripheral arterial disease. Surg Clin North Am. 1982;62:473–87.

    PubMed  CAS  Google Scholar 

  34. Laing S, Greenhalgh RM. The detection and progression of asymptomatic peripheral arterial disease. Br J Surg. 1983;70:628–30.

    Article  PubMed  CAS  Google Scholar 

  35. Lynch T, Hobson RW, Wright CB, et al. Interpretation of Doppler segmental pressures in peripheral vascular occlusive disease. Arch Surg. 1984;119:465–7.

    PubMed  CAS  Google Scholar 

  36. Fronek A, Johansen KH, Dilley RB, et al. Noninvasive physiologic tests in the diagnosis and characterization of peripheral arterial occlusive disease. Am J Surg. 1973;126:205–14.

    Article  PubMed  CAS  Google Scholar 

  37. Jelnes Gaardsting O, Jensen KH, Baekgaard Thonnesen KH. Fate in intermittent claudication: outcome and risk factors. Br Med J. 1986;293:1137–40.

    Article  Google Scholar 

  38. Sumner DS. Volume plethysmography in vascular disease: an overview. In Bernstein EF, ed. Noninvasive diagnostic techniques in vascular disease. 3rd ed. St. Louis: C. V. Mosby, 1985;97–118.

    Google Scholar 

  39. Ramsey DE, Manke DA, Sumner DS. Toe blood pressure—a valuable adjunct to ankle pressure measurement for assessing peripheral arterial disease. J Cardiovasc Surg. 1983;24:43–8.

    CAS  Google Scholar 

  40. Vollrath KD, Salles-Cunha SX, Vincent D, et al. Noninvasive measurement of toe systolic pressure. Bruit 1980;4:27–30.

    Google Scholar 

  41. Cina C, Katsamouris A, Megerman J, et al. Utility of transcutaneous oxygen tension measurements in peripheral arterial occlusive disease. J Vasc Surg. 1984;1:362–7.

    Article  PubMed  CAS  Google Scholar 

  42. Jager KA, Phillips DJ, Martin RL, et al. Noninvasive mapping of lower limb arterial lesions. Ultrasound Med Biol. 1985;11:515–21.

    Article  PubMed  CAS  Google Scholar 

  43. Kohler TR, Nance DR, Cramer MM, Vandenburghe N, Strandness DE Jr. Duplex scanning for diagnosis of aortoiliac and femoropopliteal disease: a propsective study. Circulation 1987;76:1074–80.

    PubMed  CAS  Google Scholar 

  44. Jager KA, Ricketts HJ, Strandness DE Jr. Duplex scanning for the evaluation of lower limb arterial disease. In Bernstein EF, ed. Noninvasive diagnostic techniques in vascular disease. 3rd ed. St. Louis: C. V. Mosby, 1985;619–631.

    Google Scholar 

  45. Lewis BD, James EM, Welch TJ. Current applications of duplex and color Doppler ultrasound imaging: carotid and peripheral vascular system. Mayo Clin Proc. 1989;64:1147–57.

    PubMed  CAS  Google Scholar 

  46. Polack JF, Karmel MI, Mannick JA, O’Leary DH, Donaldson MC, Whittemore AD. Determination of the extent of lower-extremity peripheral arterial disease with color-assisted duplex sonography: comparison with angiography. AJR 1990;1550:1085–9.

    Google Scholar 

  47. Ouriel K, McDonnell AE, Metz CE, et al. A critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery. 1982;91:686–93.

    PubMed  CAS  Google Scholar 

  48. Goodreau JJ. Rational approach to the differentiation of vascular and neurogenic claudication. Surgery. 1978;84:749–57.

    PubMed  CAS  Google Scholar 

  49. Carter SA. Response of ankle systolic pressure to leg exercise in mild or questionable arterial disease. N Engl J Med. 1972;287;578–82.

    Article  PubMed  CAS  Google Scholar 

  50. Thiele BL, Strandness DE. Accuracy of angiographic quantification of peripheral atherosclerosis. Progr Cardiovasc Dis. 1983;26:223–35.

    Article  CAS  Google Scholar 

  51. Bruins SH, Strihbosch L, Greep JM. Inter-observer variability in single plane aortography. Surgery. 1981;90:497–503.

    Google Scholar 

  52. Hessel SJ, Adams DF, Abrams HL. Complications of angiography. Radiology. 1981;138:273–81.

    PubMed  CAS  Google Scholar 

  53. Rose JS. Contrast media, complications, and preparation of the patient. In Rutherford RB, ed. Vascular surgery. 2nd ed. Philadelphia: W.B. Saunders, 1984;244–52.

    Google Scholar 

  54. Kannel WB, Shurtleff D. Cigarettes and the development of intermittent claudication. Geriatrics. 1973;28:61–8.

    PubMed  CAS  Google Scholar 

  55. Rosen A, DePalma RG, Victor Y. Risk factors in atherosclerosis. Arch Surg. 1973;107:303–8.

    PubMed  CAS  Google Scholar 

  56. Quick CRG, Cotton LT. The measured effect of stopping smoking on intermittent claudication. Br J Surg. 1982;69(suppl):524–6.

    Google Scholar 

  57. Ameli FM, Stein M, Provan JL, Prosser R. The effect of postoperative smoking on femoropopliteal bypass graphs. Ann Vasc Surg. 1989;3:20–5.

    Article  PubMed  CAS  Google Scholar 

  58. Ernst E. Physical exercise for peripheral vascular disease—a review. Vasa. 1987;16:227–31.

    PubMed  CAS  Google Scholar 

  59. Skinner JS, Strandness DE. Exercise and intermittent claudication. I. Effect of repetition and intensity of exercise. Circulation. 1967;36:15–22.

    PubMed  CAS  Google Scholar 

  60. Skinner JS, Strandness DE. Exercise and intermittent claudication. II. Effect of physical training. Circulation. 1967;36:23–9.

    PubMed  CAS  Google Scholar 

  61. Ernst EE, Matrai A. Intermittent claudication, exercise, and blood rheology. Circulation. 1987;76:1110–4.

    PubMed  CAS  Google Scholar 

  62. Larsen OA, Lassen NA. Effect of daily muscular exercise in patients with intermittent claudication. Lancet. 1966;2:1093–6.

    Article  PubMed  CAS  Google Scholar 

  63. Schoop W. Mechanism of beneficial action of daily walking training of patients with intermittent claudication. Scand J Clin Lab Invest. 1973;31(suppl 128):197–9.

    Google Scholar 

  64. Dahllof AG, Bjorntorp P, Holm J, Schersten T. Metabolic activity of skeletal muscle in patients with peripheral arterial insufficiency. Eur J Clin Invest. 1974;4:9–15.

    Article  PubMed  CAS  Google Scholar 

  65. Eckroth R, Dahllof AG, Gundevall B, Holm J, Schersten T. Physical training of patients with intermittent claudication: indications, methods, and results. Surgery. 1978;84:640–3.

    Google Scholar 

  66. Robertson WB, Strong JP. Atherosclerosis in persons with hypertension and diabetes mellitus. Lab Invest. 1968;18:538–51.

    PubMed  CAS  Google Scholar 

  67. Chobanian AV. The influence of hypertension and other hemodynamic factors in atherogenesis. Progr Cardiovasc Dis. 1983;26:177–96.

    Article  CAS  Google Scholar 

  68. Furberg CD, Byington RP, Borhani N, et al. Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). Am J Med. 1989;86S4A:37–9.

    Article  Google Scholar 

  69. Rutan G, Kuller LH, Neaton JD, et al. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation. 1988;77:504–14.

    PubMed  CAS  Google Scholar 

  70. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1988;148:1023–38.

    Article  Google Scholar 

  71. National Education Programs Working Group Report on the Management of Patients with Hypertension and High Blood Cholesterol. Ann Intern Med. 1991;114:224–37.

    Google Scholar 

  72. Stamler R, Stamler J, Grimm R, et al. Nutritional therapy for high blood pressure. JAMA. 1987;257:1484–91.

    Article  PubMed  CAS  Google Scholar 

  73. MacMahon SW, Cutler JA, Furberg CD, et al. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Progr Cardiovasc Dis 1986;29(suppl 1):99–118.

    Article  CAS  Google Scholar 

  74. Grimm RH, Leon AS, Hunninghake DB, et al. Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients. A double-blind controlled trial. Ann Intern Med. 1981;94:7–11.

    PubMed  Google Scholar 

  75. Bogaert MG, Clement DL. Lack of influence of propranolol in intermittent claudication. Eur Heart J. 1983;4:203–4.

    PubMed  CAS  Google Scholar 

  76. Reichert, Shibolet S, Adar R, Gafni J. Controlled trial of propranolol in intermittent claudication. Clin Pharmacol Ther. 1975;17:612–5.

    PubMed  CAS  Google Scholar 

  77. Rodger JC, Sheldon CB, Lerski RA, Livingstone WR. Intermittent claudication complicating beta-blockade. Br Med J. 1976;i:1125.

    Article  Google Scholar 

  78. Frohlich ED, Tarazi RC, Dustan HP. Peripheral arterial insufficiency. A complication of beta-adrenergic therapy. JAMA. 1969;208:2471–2.

    Article  PubMed  CAS  Google Scholar 

  79. Fogoros RN. Exacerbation of intermittent claudication by propranolol. N Engl J Med. 1980;302:1089.

    PubMed  CAS  Google Scholar 

  80. Roberts DH, Tsao Y, McLoughlin GA, Breclemrodge A. Placebocontrolled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication. Lancet. 1987;2:650–3.

    Article  PubMed  CAS  Google Scholar 

  81. Coffman JD. Vasodilator drugs in peripheral vascular disease. N Engl J Med. 1979;300:713–7.

    Article  PubMed  CAS  Google Scholar 

  82. Snyder SH, Reynolds IH. Calcium-antagonist drugs: receptor interactions that clarify therapeutic effects. N Engl J Med. 1985;313:995–1002.

    Article  PubMed  CAS  Google Scholar 

  83. Weinstein DB, Heider JG. Antiatherogenic properties of calcium antagonists: state of the art. Am J Med. 1989;86(4A)27–32.

    Article  PubMed  CAS  Google Scholar 

  84. Kannel WB, Skinner JJ, Schwartz MJ, et al. Intermittent claudication. Incidence in the Framingham study. Circulation. 1970;41:875–83.

    PubMed  CAS  Google Scholar 

  85. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med. 1988;148:36–61.

    Google Scholar 

  86. Blankenhorn DH, Nessim SA, Johnson RL, et al. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA. 1987;257:3233–40.

    Article  PubMed  CAS  Google Scholar 

  87. Brown BG, Lin JT, Schafer SM, Kaplan CA, Dodge HT, Albers JJ. Niacin or lavastatin, combined with colestipol, regress coronary atherosclerosis and prevent clinical events in men with elevated apolipoprotein B. Circulation. 1989;80:suppl II:II-266 (abstr).

    Google Scholar 

  88. Nikkila EA, Viikinkoski P, Valle M, Frick MH. Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven-year prospective study. Br Med J. 1984;289:220–3.

    Article  CAS  Google Scholar 

  89. Duffield RGM, Lewis B, Miller NE, et al. Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. Lancet. 1983;2:639–42.

    Article  PubMed  CAS  Google Scholar 

  90. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results. I. Reduction in incidence of coronary heart disease. JAMA. 1984;251:351–64.

    Article  Google Scholar 

  91. Buchwald H, Varco RL, Matts JP, et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. N Engl J Med. 1990;323:946–55.

    Article  PubMed  CAS  Google Scholar 

  92. Jonason T. Ringvist I. Diabetes mellitus and intermittent claudication: relation between peripheral vascular complications and location of the occlusive atherosclerosis in the legs. Acta Med Scand. 1985;218:217–21.

    Article  PubMed  CAS  Google Scholar 

  93. Jonason T, Ringqvist I. Factors of prognostic importance for subsequent rest pain in patients with intermittent claudication. Acta Med Scand. 1985;218:27–33.

    Article  PubMed  CAS  Google Scholar 

  94. Malone JM, Snyder M, Anderson G, Bernhard VM, Holloway GA, Bunt TJ. Prevention of amputation by diabetic education. Am J Surg. 1989;158:520–3.

    Article  PubMed  CAS  Google Scholar 

  95. Clagett GP, Genton E, Salzman EW. Antithrombotic therapy in peripheral vascular disease. Chest. 1989;95(suppl):128S-39S.

    Article  PubMed  CAS  Google Scholar 

  96. Jones NAG, DeHaas H, Zahavi J, Kakkar VV. A double-blind trial of suloctidil v placebo in intermittent claudication. Br J Surg. 1982;69:38–40.

    Article  PubMed  CAS  Google Scholar 

  97. Katsumura T, Mishima Y, Kamiya K, Sakaguchi S, Tanabe T, Sakuma A. Therapeutic effect of ticlopidine, a new inhibitor of platelet aggregation on chronic arterial occlusive disease, a double-blind study versus placebo. Angiology. 1982;33:357.

    Article  PubMed  CAS  Google Scholar 

  98. Hess H, Miewtaschik A, Deischsel G. Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease; a prospective double-blind arteriographically controlled trial. Lancet. 1985;1:415–19.

    Article  PubMed  CAS  Google Scholar 

  99. Antiplatelet Trialists’ Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J. 1988;296:320–3.

    Article  Google Scholar 

  100. Research Study Group. Preliminary report: findings from the aspirin component of the ongoing physicians’ health study. N Engl J Med. 1988;318:262–64.

    Article  Google Scholar 

  101. Peto R, Gray R, Collins R, et al. Randomized trial of prophylactic daily aspirin in British male doctors. Br Med J. 1988;296:313–16.

    Article  CAS  Google Scholar 

  102. Bounameaux H, Holditch T, Hellemans H, et al. Placebo-controlled double-blind two-centre trial of ketanserin in intermittent claudication. Lancet 1985;2(8467):1268.

    Article  PubMed  CAS  Google Scholar 

  103. Leaf A, Weber PC. Cardiovascular effects of n-3 fatty acids. N Engl J Med. 1988;318:549–57.

    Article  PubMed  CAS  Google Scholar 

  104. Jeans WD, Danton RM, Baird RN, Horrocks M. The effects of introducing balloon dilatation into vascular surgical practice. Br J Radiol. 1986;59:457–9.

    Article  PubMed  CAS  Google Scholar 

  105. Anderson JB, AWolinski AP, Wells IP, Wilkins DC, Bliss RP. The impact of percutaneous transluminal angioplasty on the management of peripheral vascular disease. Br J Surg. 1986;73:17–9.

    Article  PubMed  CAS  Google Scholar 

  106. McKlean L, Jeans WD, Horrocks M, Baird RN. The place of percutaneous transluminal angioplasty in the treatment of patients having angiography for ischaemic disease of the lower limb. Clin Radiol. 1987;38:157–60.

    Article  Google Scholar 

  107. Widlus DM, Osterman FA. Evaluation and percutaneous management of atherosclerotic peripheral vascular disease. JAMA. 1989;261:3148–54.

    Article  PubMed  CAS  Google Scholar 

  108. Johnston W, Rae M, Jogg-Johnston SA, et al. Five-year results of a prospective study of percutaneous transluminal angioplasty. Ann Surg. 1987;206:403–13.

    Article  PubMed  CAS  Google Scholar 

  109. Joly S, Bonan R, Palisaitis D, et al. Treatment of recurrent restenosis with repeat percutaneous transluminal coronary angioplasty. Am J Cardiol. 1988;61:906–8.

    Article  PubMed  CAS  Google Scholar 

  110. Wilson SE, White GH, Wolf G, et al. Proximal percutaneous balloon angioplasty and distal bypass for multilevel arterial occlusion. Ann Vasc Surg. 1990;4:351–5.

    Article  PubMed  CAS  Google Scholar 

  111. Wilson SE, Wolf GL, Cross AP. Percutaneous transluminal angioplasty versus operation for peripheral arteriosclerosis. Report of a prospective randomized trial in a selected group of patients. J Vasc Surg. 1989;9:1–9.

    Article  PubMed  CAS  Google Scholar 

  112. Jeans WD, Danton RM, Baird RN, Horrocks M. A comparison of the costs of vascular surgery and balloon dilatation in lower limb ischaemic disease. Br J Radiol. 1986;59:453–6.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of General Internal Medicine (111-0), Minneapolis Veterans Affairs Medical Center, 1 Veterans Drive, 55417, Minneapolis, MN

    Timothy J. Wilt MD, MPH

Authors
  1. Timothy J. Wilt MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received from the Section of General Internal Medicine, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilt, T.J. Current strategies in the diagnosis and management of lower extremity peripheral vascular disease. J Gen Intern Med 7, 87–101 (1992). https://doi.org/10.1007/BF02599110

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02599110

Keywords

Search

Navigation